Trials / Completed
CompletedNCT05360628
Evaluation of PK and Safety of D-0120 and Allopurinol
A Phase I, Randomized, Open-label Study to Evaluate the Potential Pharmacokinetic Interactions Between D-0120 and Allopurinol in Healthy Adult Subjects
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- InventisBio Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D-0120 in combination with Allopurinol | noted above |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-02-10
- Completion
- 2022-07-23
- First posted
- 2022-05-04
- Last updated
- 2023-03-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05360628. Inclusion in this directory is not an endorsement.